UnitedHealth Group Incorporated $UNH Position Lifted by Country Club Bank

Country Club Bank raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 120.6% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 18,567 shares of the healthcare conglomerate’s stock after purchasing an additional 10,151 shares during the period. Country Club Bank’s holdings in UnitedHealth Group were worth $5,739,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP boosted its holdings in UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares during the period. Bank of New York Mellon Corp raised its holdings in shares of UnitedHealth Group by 2.5% during the first quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock worth $4,257,131,000 after purchasing an additional 196,696 shares during the period. Nuveen LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at about $3,846,764,000. Finally, Charles Schwab Investment Management Inc. raised its stake in UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock worth $3,702,736,000 after acquiring an additional 847,054 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Down 0.3%

Shares of UnitedHealth Group stock opened at $358.95 on Tuesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The business has a fifty day simple moving average of $309.38 and a 200-day simple moving average of $352.34. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The firm has a market cap of $325.09 billion, a price-to-earnings ratio of 15.55, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the company posted $6.80 earnings per share. UnitedHealth Group’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on UNH shares. Royal Bank Of Canada lowered their target price on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. JPMorgan Chase & Co. dropped their target price on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 6th. Barclays upped their price target on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Bank of America boosted their target price on shares of UnitedHealth Group from $290.00 to $325.00 and gave the company a “neutral” rating in a research note on Monday, August 18th. Finally, Morgan Stanley lifted their price target on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.